—

Novo Nordisk A/S(NVO)— 同类公司组

数据截至2026-11-20 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Novo Nordisk A/S的Closelook综合评分为55/100,在同类公司组内排名第16位(共16家)——组内评分最高的是Wise plc(68/100)。

名称综合动量质量估值信号距52周高点
NVO Novo Nordisk A/S55308572bear37.2%
WISE.L Wise plc68398054bear25.9%
DECK Deckers Outdoor Corporation67267972bear35.4%
RACE Ferrari NV66758324bull7.3%
REGN Regeneron Pharmaceuticals Inc65897346watch7%
LLY Eli Lilly and Company64879022neutral8.4%
HDB HDFC Bank Limited ADR63626577watch27.7%
DXCM DexCom Inc62687834watch13.4%
TOST Toast Inc62715041bear19.8%
GMED Globus Medical61306657bear32.3%
VRSK Verisk Analytics Inc61738933bull16.8%
IDXX IDEXX Laboratories Inc60768517bull10.4%
DB1.DE Deutsche Börse AG59897736neutral3.7%
ORNAV.HE Orion Oyj A63958428ok3.5%
ORNBV.HE Orion Oyj B63958428ok3.5%
SAN.PA Sanofi SA63756962bull5.9%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-20

Quick answers

Novo Nordisk A/S在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Wise plc (WISE.L)、Deckers Outdoor Corporation (DECK)、Ferrari NV (RACE)、Regeneron Pharmaceuticals Inc (REGN)、Eli Lilly and Company (LLY)、HDFC Bank Limited ADR (HDB)、DexCom Inc (DXCM)、Toast Inc (TOST)等。

NVO相对同类公司的评分如何?

Novo Nordisk A/S的综合评分为55/100,组内排名第16位(共16家),截至2026-11-20;组内最高综合评分为Wise plc(68/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.